Investigation of tissue factor pathway inhibitor promoter polymorphisms in patients with antiphospholipid syndrome: decreased TFPI activity in a patient homozygous for the T-287-C polymorphism
conference contribution
posted on 2023-05-24, 08:49authored byScorgie, F, Lincz, LF, Adams, MJ, Baker, R, Seldon, M
No description available
History
Publication title
Proceedings of the 6th Combined ASM of the HSANZ/ANZBT/ASTH